Exploring the optimal reference to estimate the effect of anti-inflammatory therapy for the cardiac sarcoidosis -metabolic volume assessment of FDG PET-

Conclusions: We measured the FDG uptake in the liver and blood pool before and during steroid therapy. Steroid therapy might be increase the liver FDG uptake because of its effect on glyceroneogenesis in the liver and adipose tissue. However, the blood pool uptake didn’t show significant differences. Our findings revealed that the DA is suitable threshold rather than liver uptake to evaluate the therapy effect using volume-based analysis of cardiac FDG PET.

Source: Journal of Nuclear Medicine - May 23, 2018 Category: Nuclear Medicine Authors: Furuya, S., Hirata, K., Manabe, O., Hiroshi, O., Naya, M., Aikawa, T., Koyanagawa, K., Tsujino, I., Shiga, T., Kudo, K. Tags: Cardiovascular Clinical Science Poster Session Source Type: research